J. C. Cervellino

Sequential versus Alternating Regimens in the Treatment of Advanced Breast Cancer

J. Villalba, S. Jovtis, C. Blajman, 1989, Tumori.

Ifosfamide and mesna at high doses for the treatment of cancer of the cervix: a GETLAC study

C. E. Araújo, R. Rossi, J. C. Cervellino, 2004, Cancer Chemotherapy and Pharmacology.

Ifosfamide and mesna for the treatment of advanced squamous cell head and neck cancer. A GETLAC study.

A. Francia, R. Cerruti, C. E. Araújo, 1991, Oncology.

Chemotherapy with high dose ifosfamide/mesna plus cisplatin for the treatment of ovarian cancer: A study of the Grupo de Estudio y Tratamiento Latino‐Americano del cancer

C. E. Araújo, J. C. Cervellino, C. Pirisi, 1991, Journal of surgical oncology.

Cisplatin and ifosfamide in patients with advanced squamous cell carcinoma of the uterine cervix. A phase II trial.

C. E. Araújo, J. C. Cervellino, O. Sánchez, 1995, Acta oncologica.

Transferring the financial risks of pharmaceutical benefits from a large health care provider in Argentina to a consortium of pharmaceutical companies.

R. Diez, I. Bignone, J. C. Cervellino, 2003, Revista panamericana de salud publica = Pan American journal of public health.

Phase I study of VRCTC-310, a purified phospholipase A2 purified from snake venom, in patients with refractory cancer: safety and pharmacokinetic data

R. Diez, C. E. Araújo, J. C. Cervellino, 1997, Anti-cancer drugs.

Treatment of Non-Small Cell Lung Cancer with Ifosfamide (IFO) + 4’-Epiadriamycin (EPI) + Platinum vs. IFO + EPI: A GETLAC Study

G. Témperley, C. E. Araújo, L. Balbiani, 1995 .

Combined hormonal therapy with high‐dose diethylstilbestrol diphosphate (DES‐DP) intravenous infusion plus vindesine (VND) for the treatment of advanced prostatic carcinoma: A controlled study

C. E. Araújo, J. C. Cervellino, C. Pirisi, 1990, Journal of surgical oncology.